VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 35 filers reported holding VINCERX PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $94,667 | -84.0% | 116,873 | 0.0% | 0.00% | -88.2% |
| Q1 2024 | $591,377 | +41.4% | 116,873 | -67.0% | 0.02% | +88.9% |
| Q4 2023 | $418,165 | +16.8% | 354,377 | 0.0% | 0.01% | -30.8% |
| Q3 2023 | $357,921 | -22.3% | 354,377 | 0.0% | 0.01% | -35.0% |
| Q2 2023 | $460,690 | +14.5% | 354,377 | -8.4% | 0.02% | +100.0% |
| Q1 2023 | $402,188 | +2.0% | 386,719 | 0.0% | 0.01% | -41.2% |
| Q4 2022 | $394,453 | -86.4% | 386,719 | -81.6% | 0.02% | -88.4% |
| Q3 2022 | $2,908,000 | +4.6% | 2,107,000 | 0.0% | 0.15% | 0.0% |
| Q2 2022 | $2,781,000 | -67.0% | 2,107,000 | 0.0% | 0.15% | -52.1% |
| Q1 2022 | $8,428,000 | -47.9% | 2,107,000 | +32.8% | 0.30% | -60.1% |
| Q4 2021 | $16,164,000 | -23.8% | 1,586,245 | +20.9% | 0.76% | +28.8% |
| Q3 2021 | $21,222,000 | +206.1% | 1,312,406 | +145.9% | 0.59% | +36.0% |
| Q2 2021 | $6,932,000 | – | 533,668 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 1,492,771 | $1,552,482 | 0.51% |
| SAGE RHINO CAPITAL LLC | 1,686,937 | $1,754,414 | 0.51% |
| SABBY MANAGEMENT, LLC | 353,400 | $367,536 | 0.32% |
| Tejara Capital Ltd | 290,882 | $302,517 | 0.16% |
| Long Focus Capital Management, LLC | 1,414,951 | $1,471,549 | 0.08% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $400,400 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $106,131 | 0.05% |
| Rock Springs Capital Management LP | 891,719 | $927,388 | 0.02% |
| Clearline Capital LP | 98,916 | $102,872 | 0.02% |
| TANG CAPITAL MANAGEMENT LLC | 101,762 | $105,832 | 0.02% |